Why the study?
Does Thrombospondin 1 aggravate cardiac remodeling in HFpEF by inhibiting mitophagy?
Does Thrombospondin 1 aggravate cardiac remodeling in HFpEF by inhibiting mitophagy?
Thrombospondin 1 aggravates cardiac remodeling in HFpEF by inhibiting mitophagy, highlighting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Thrombospondin 1 inhibition merits preclinical validation in HFpEF; leaves open its viability as a clinical target.
as a key suppressor of mitophagy in HFpEF and a potential therapeutic target for this prevalent condition.
No takes yet. Share an insight, caveat, or question.
Bu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: